Pliant Share Price

Pliant Share Price

NASDAQ: PLRX | Micro Cap | Healthcare
$0.66
+$0.00 (0.34%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Pliant Stock Performance

Open
$0.66
Prev. Close
$0.66
Circuit Range
N/A
Day Range
$0.64 - $0.67
Year Range
$0.64 - $1.66
Volume
24,813
Average Traded
$0.65

Pliant Share Price Today

As of 19 November 2026, Pliant Therapeutics, Inc.'s share price is $0.66. The stock opened at $0.66, compared to its previous close of $0.66. During today's trading session, Pliant Therapeutics, Inc.'s share price traded between $0.64 and $0.67, with an average price of $0.65. Over the past 52 weeks, the stock has recorded a high of $1.66 and a low of $0.64. In terms of performance, Pliant Therapeutics, Inc.'s share price has declined by 48.24% over the last six months and is down 59.17% on a year-on-year basis.

Pliant Share Price Chart

Line chart of the Pliant price trend over the selected period. The price rose overall, ranging from 0.64 to 0.67, ending at 0.66.
$0.64$0.67
L
Show Current Price
H

Pliant Stock Fundamentals & Key Indicators

Market Cap
$40.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.46
Revenue (TTM)
$0.00
Return On Equity (TTM)
-71.36%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-3.39%

Pliant Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$23.58-$20.04-$22.37-$24.38
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A15.01%-11.63%-8.99%

Pliant Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.69$1.58$0.00$0.00
Net Profit-$123.32-$161.34-$210.30-$149.34
Net Profit Margin-1272.65%-10211.39%N/AN/A
Income ChangeN/A-30.83%-30.35%28.99%

Pliant Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets28.7834.696.6510.3
Current Assets196.45362.26505.5340.31
Total Assets225.23396.95512.15350.61
Non Current Liabilities27.6659.6510.0513.36
Current Liabilities16.3733.2228.5223.91
Total Liabilities44.0292.8738.5837.27
Shareholders' Equity181.21304.08473.58313.34

Pliant Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-128.34-155.5-116.36-94.63
Investing134.29140.34-127.01-150.2
Financing-31.723.12274.41226.85

About Pliant

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Pliant Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.85
$0.65
-23.38%
Oct 2026
$1.09
$0.85
-21.20%
Sep 2026
$1.10
$1.08
-6.49%
Aug 2026
$1.05
$1.16
+10.53%
Jul 2026
$1.15
$1.04
-8.33%
Jun 2026
$1.25
$1.14
-10.24%
May 2026
$1.22
$1.27
+3.67%
Apr 2026
$1.29
$1.23
-3.92%
Mar 2026
$1.26
$1.27
-1.16%
Feb 2026
$1.22
$1.29
+5.74%
Jan 2026
$1.23
$1.22
+0.83%
Dec 2025
$1.58
$1.21
-24.84%

Pliant Share Price FAQs